Study Purpose
The Immune Sub Study has been developed as a sub-protocol of the Canadian COVID-19 Vaccine Registry for Pregnant and Lactating Individuals (COVERED). The larger vaccine study aims to assess safety, effectiveness, and acceptability of COVID-19 vaccination in pregnant individuals. The sub-study aims to enable a better understanding of the immune response of the COVID-19 vaccine generated during pregnancy.
Initial engagement has been established at BC Women’s Hospital with the potential for additional sites throughout BC
Study Objectives
- To examine immune response to COVID-19 vaccination in pregnant individuals
- To measure IgG and IgA antibody levels in breastmilk samples
Study Eligibility
- Currently pregnant or lactating
- 19 years of age or older
- Able to communicate in English
- Scheduled to or have been vaccinated with a COVID-19 vaccination
- Registered to deliver at BC Women’s Hospital
For further information regarding the study or to ask questions, please contact us via email at covered.covid@ubc.ca